Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2025-07-25 00:00:00 ET · period of report 2025-07-23 · accession 0000950170-25-098774 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-25 | 2025-07-23 | NTLA | Dulac Edward J III | EVP, CFO | S - Sale | $14.02 | -7,462 | 106.1K | -7% | -$104.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-23 | S | D | 7,462 | $14.02 | 106,062 | D | — | — |